‹ ›

This content requires a premium subscription.
Please log in or subscribe to continue.
Artwork for Applying Advances in Cell Cycle Biology to Inhibit CDK2 and CDK9 to Overcome Resistance to Anti-Cancer Therapies with Spiro Rombotis Cyclacel Pharmaceuticals
Empowered Patient Podcast

Applying Advances in Cell Cycle Biology to Inhibit CDK2 and CDK9 to Overcome Resistance to Anti-Cancer Therapies with Spiro Rombotis Cyclacel Pharmaceuticals
30
00:00:00 / 00:17:05